James J. Collins - Insider Trading & Ownership

Entity
Individual
Location
C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA
All Insider Reports
All Insider Reports

Ownership of James J. Collins

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
FULC Fulcrum Therapeutics, Inc. Director Jun 17, 2024
ORIA Orion Biotech Opportunities Corp. Director May 17, 2023
SNTI Senti Biosciences, Inc. Director Jul 10, 2024

Insider Transactions Reported by James J. Collins:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.